Profile data is unavailable for this security.
About the company
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
- Revenue in USD (TTM)770.01m
- Net income in USD-141.45m
- Incorporated2008
- Employees2.40k
- LocationTandem Diabetes Care Inc12400 High Bluff DriveSAN DIEGO 92130United StatesUSA
- Phone+1 (858) 366-6900
- Fax+1 (302) 636-5454
- Websitehttps://www.tandemdiabetes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premier Inc | 1.34bn | 80.33m | 2.00bn | 2.80k | 29.65 | 1.04 | 10.14 | 1.49 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Warby Parker Inc | 697.80m | -55.06m | 2.00bn | 2.14k | -- | 6.31 | -- | 2.86 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.07bn | 1.06k | 136.33 | 5.27 | 100.10 | 6.35 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.13bn | 7.60k | 11.74 | 2.21 | 7.62 | 0.3249 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
| Conmed Corp | 1.26bn | 82.35m | 2.25bn | 4.00k | 27.88 | 2.63 | 14.59 | 1.78 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Helen of Troy Limited | 2.01bn | 168.59m | 2.47bn | 1.93k | 14.69 | 1.50 | 11.20 | 1.23 | 7.05 | 7.05 | 83.65 | 68.94 | 0.6971 | 2.48 | 5.19 | 1,040,503.00 | 5.86 | 7.69 | 6.90 | 9.53 | 47.31 | 44.32 | 8.41 | 9.24 | 0.9936 | 5.27 | 0.289 | -- | -3.26 | 5.09 | 17.67 | -0.6548 | 6.79 | -- |
| ICU Medical Inc | 2.26bn | -59.31m | 2.54bn | 14.00k | -- | 1.23 | 14.92 | 1.13 | -2.46 | -2.46 | 93.27 | 84.87 | 0.5154 | 2.12 | 15.86 | 161,223.70 | -1.35 | 1.46 | -1.51 | 1.65 | 32.48 | 34.11 | -2.63 | 2.23 | 1.09 | 0.4817 | 0.4393 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Enovis Corp | 1.82bn | -103.33m | 2.74bn | 6.55k | -- | 0.8293 | 20.22 | 1.51 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Inari Medical Inc | 520.66m | -23.62m | 2.76bn | 1.30k | -- | 6.15 | -- | 5.30 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Envista Holdings Corp | 2.56bn | -120.40m | 3.09bn | 12.80k | -- | 0.7461 | 283.33 | 1.21 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| Tandem Diabetes Care Inc | 770.01m | -141.45m | 3.21bn | 2.40k | -- | 13.20 | -- | 4.17 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| LivaNova PLC | 1.19bn | -31.77m | 3.22bn | 2.90k | -- | 2.63 | 191.07 | 2.71 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Procept Biorobotics Corp | 156.33m | -103.37m | 3.43bn | 626.00 | -- | 12.99 | -- | 21.95 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Axonics Inc | 387.14m | -15.95m | 3.44bn | 797.00 | -- | 5.48 | -- | 8.87 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Integer Holdings Corp | 1.63bn | 98.09m | 4.08bn | 10.50k | 42.30 | 2.68 | 20.51 | 2.50 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Haemonetics Corporation | 1.31bn | 117.56m | 4.50bn | 3.66k | 38.75 | 4.69 | 20.96 | 3.44 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
Data as of May 24 2024. Currency figures normalised to Tandem Diabetes Care Inc's reporting currency: US Dollar USD
54.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 8.09m | 12.53% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 6.96m | 10.78% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 3.67m | 5.68% |
| Marshall Wace LLPas of 31 Mar 2024 | 3.12m | 4.83% |
| ArrowMark Colorado Holdings LLCas of 31 Mar 2024 | 2.93m | 4.55% |
| Jennison Associates LLCas of 31 Mar 2024 | 2.56m | 3.96% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.24m | 3.47% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 2.17m | 3.36% |
| Bellevue Asset Management AGas of 31 Mar 2024 | 2.03m | 3.15% |
| Champlain Investment Partners LLCas of 31 Mar 2024 | 1.51m | 2.34% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
